Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on improving patient safety and aesthetic outcomes, is disrupting plastic surgery through the design, development, manufacturing and marketing of an innovative portfolio of silicone gel-filled breast implants. Recognizing the need for an enhanced safety profile and improved patient satisfaction, ESTA has set out to redefine the approach for breast aesthetics and reconstruction through innovation and science. Motiva Implants® are approved for commercial distribution in over 70 countries worldwide.